An Analytical Evaluation of Risk Return Dynamics of Sun Pharmaceutical Industries Ltd and Divis Laboratories Ltd in NSE

This research presents a comparative analysis of Sun Pharmaceutical Industries Ltd and Divi's Laboratories Ltd, focusing on their risk-return characteristics within the National Stock Exchange environment. By evaluating factors such as average returns, volatility levels, beta coefficients, and alpha values, the study investigates how these companies respond to market fluctuations while maximizing shareholder value. The results indicate that Divi’s Laboratories showcases stable performance with moderate market responsiveness, whereas Sun Pharma demonstrates a defensive profile with an inverse correlation to market trends. Through riskadjusted evaluation metrics like Sharpe Ratio, Treynor ratio and Jensen’s Alpha, the study reveals that both entities consistently exceed expected returns relative to their risk exposure. The result meaningful insights for investors and portfolio managers engaged in India’s pharmaceutical sector.